Camber Pharmaceuticals Inc. is pleased to announce the promotion of Mr. Konstantin Ostaficiuk to President of Camber Pharmaceuticals. Mr. Ostaficiuk, known to the industry as just Kon, is a twenty five year veteran of the generic pharmaceutical industry and brings a wealth of experience to his new position. He joined Camber Pharmaceuticals two years ago as Vice President of Sales and Marketing and has been a major factor in the rapid growth of Camber within the industry. Camber, and parent company Hetero Drugs Limited’s senior management have expressed great confidence in Mr. Ostaficiuk and look forward to his leading Camber forward for many years to come.
Mr. Ostaficiuk succeeds Briggs Arrington, founding President of Camber Pharmaceuticals. Mr. Arrington has been asked to join a Hetero Senior Management Team to explore new business opportunities for Hetero’s US manufacturing operations.
Camber Pharmaceuticals has been recognized as one of the fastest growing generic pharmaceutical companies in the US the past two years. Mr. Ostaficiuk, says “Camber and Hetero have a very robust pipeline and will continue to introduce and launch significant new products to our current portfolio in the remainder of 2011, 2012 and on into the future. Mr. Ostaficiuk stated, “We are committed to providing the highest level of quality and service available as we grow our business and our product line.”
Located at 1031 Centennial Avenue in Piscataway NJ, Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products from API manufacturing to finished dosage. Camber’s parent company Hetero Drugs of Hyderabad, India employs over 300 scientists at 9 API facilities and has a global presence in over 100 countries.
Please feel free to share this press release information with any in your organization who would have an interest.
